Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Rifampicin reduces severe hepatotoxicity and costs versus isoniazid

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    Reference

    1. Ronald LA, et al. Treatment with Isoniazid or Rifampin for Latent Tuberculosis Infection: Population-Based Study of Hepatotoxicity, Completion, and Costs. European Respiratory Journal : 24 Jan 2020. Available from: URL: http://doi.org/10.1183/13993003.02048-2019

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Rifampicin reduces severe hepatotoxicity and costs versus isoniazid. Reactions Weekly 1790, 10 (2020). https://doi.org/10.1007/s40278-020-74629-z

    Download citation